These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31590928)

  • 1. Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer.
    Zhan M; Wang H; Xu SW; Yang LH; Chen W; Zhao SX; Shen H; Liu Q; Yang RM; Wang J
    EBioMedicine; 2019 Oct; 48():143-160. PubMed ID: 31590928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
    Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
    Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
    Kiesslich T; Mayr C; Neureiter D
    EBioMedicine; 2019 Nov; 49():9-10. PubMed ID: 31648982
    [No Abstract]   [Full Text] [Related]  

  • 4. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
    Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
    Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
    Okumura Y; Noda T; Eguchi H; Sakamoto T; Iwagami Y; Yamada D; Asaoka T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2018 Nov; 25(12):3728-3737. PubMed ID: 30105440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.
    Wang N; Song L; Xu Y; Zhang L; Wu Y; Guo J; Ji W; Li L; Zhao J; Zhang X; Zhan L
    EBioMedicine; 2019 Sep; 47():65-77. PubMed ID: 31495720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
    Meng LQ
    Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
    Kitamura T; Srivastava J; DiGiovanni J; Kiguchi K
    Mol Carcinog; 2015 Jun; 54(6):459-72. PubMed ID: 24839254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
    Yeung Y; Lau DK; Chionh F; Tran H; Tse JWT; Weickhardt AJ; Nikfarjam M; Scott AM; Tebbutt NC; Mariadason JM
    Mol Oncol; 2017 Sep; 11(9):1130-1142. PubMed ID: 28544747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells.
    Nguyen Ho-Bouldoires TH; Clapéron A; Mergey M; Wendum D; Desbois-Mouthon C; Tahraoui S; Fartoux L; Chettouh H; Merabtene F; Scatton O; Gaestel M; Praz F; Housset C; Fouassier L
    Free Radic Biol Med; 2015 Dec; 89():34-46. PubMed ID: 26169728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
    Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M
    Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling.
    Guan L; Zhang L; Gong Z; Hou X; Xu Y; Feng X; Wang H; You H
    Hepatology; 2016 Jun; 63(6):1914-27. PubMed ID: 26857210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation.
    Yu KD; Huang AJ; Fan L; Li WF; Shao ZM
    Cancer Res; 2012 Jan; 72(2):408-19. PubMed ID: 22147260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
    Shim GS; Manandhar S; Shin DH; Kim TH; Kwak MK
    Free Radic Biol Med; 2009 Dec; 47(11):1619-31. PubMed ID: 19751820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
    Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
    Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.
    Li PC; Tu MJ; Ho PY; Jilek JL; Duan Z; Zhang QY; Yu AX; Yu AM
    Drug Metab Dispos; 2018 Jan; 46(1):2-10. PubMed ID: 29061583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.
    Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN
    FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.
    Shin JH; Lee KM; Shin J; Kang KD; Nho CW; Cho YS
    Genes Genomics; 2019 May; 41(5):537-545. PubMed ID: 30767168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.